This page gives details of CPPsite entry with ID 2469 |
| Primary information | |
|---|---|
| CPPsite ID | 2469 |
| PEPTIDE SEQUENCE | WEARLARALARALARHLARALARALRACEA |
| PEPTIDE NAME | RALA |
| CHIRALITY | L |
| LINEAR/CYCLIC | Linear |
| SOURCE | Synthetic |
| CATEGORY | Cationic and amphipathic |
| SUB CELLULAR LOCALIZATION | Nucleus |
| N-TERMINAL MODIFICATION | Free |
| C-TERMINAL MODIFICATION | Free |
| UPTAKE EFFICIENCY | RALA/pDNA nanoparticles in vitro is comparable with commercial transfecting agents while exhibiting significantly lower cytotoxicity |
| PROPOSED UPTAKE MECHANISM | Endocytic pathway |
| INVITRO/INVIVO | In vitro and in vivo |
| CELL LINE | ZR-75-1, PC-3 and NCTC-929 |
| In VIVO MODEL | Female C57BL/6 mice |
| CARGO | Nanoparticle (Cy3-labeled nanoparticles complexed with DNA) |
| PMID | 24995949 |
| PATENT | Unknown |
| LENGTH | 30 |
| Secondary Structure | CCSTTHHHHTTTHHHHHHHHHHHHHTSSCC |
| SMILES | N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](Cc1nc[nH]c1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](C)C(=O)N[C@ |
| Tertiary Structure (Technique) | View in Jmol  OR Download Structure (PEPstrMOD) |